JPMorgan raised the firm’s price target on Procter & Gamble to $181 from $170 and keeps an Overweight rating on the shares as part of a Q2 preview last week for the household and personal care space. The firm expects another “subdued” earnings season for the 15 stocks it covers, saying most companies are seeing a deceleration in organic sales sequentially as pricing benefits rolled over and private label regained share. However, the sector continues to look relatively better versus beverages, and the high-quality names are good places to “hide,” the analyst tells investors in a research note. JPMorgan established December 2025 price targets across the group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $174 from $170 at Barclays
- Procter & Gamble price target raised to $183 from $177 at Evercore ISI
- Procter & Gamble price target raised to $176 from $171 at Deutsche Bank
- Procter & Gamble price target raised to $190 from $177 at Citi
- Procter & Gamble Unveils Stock Market Investment Strategies